Commonwealth Numbered Regulations

1983 No. 292 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 5

SCHEDULE 5
Regulation 6 AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL
BENEFITS) REGULATIONS
1. Omit item 43, substitute the following items:
   "43 Cimetidine, Tablets, 200 mg          With the written authority of the

Permanent Head-
Duodenal ulcer, confirmed by
radiology, endoscopy or surgery
Gastric ulcer, confirmed by
radiology, endoscopy or surgery
Zollinger-Ellison syndrome,
proven by investigation
    43A Cimetidine, Tablets, 400 mg         With the written authority of the

Permanent Head-
Duodenal ulcer, confirmed by
radiology, endoscopy or surgery
Zollinger-Ellison syndrome,
proven by investigation".
2. After item 54, insert the following item:
   "54A Demeclocycline Capsules, B.P.       With the written authority of the

Permanent Head-
Syndrome of inappropriate
antidiuretic hormone secretion,
caused otherwise than by treatment
with a drug".
3. Omit item 66.
4. Omit item 68.
5. Omit item 95, substitute the following item:
   "95 Lactulose                            With the written authority of the

Permanent Head-
Hepatic coma or pre-coma (chronic
porto-systemic encephalopathy)
Terminal malignant neoplasia".
6. After item 141, insert the following item:

"141A (1) Phenylbutazone, B.P.

(2) Phenylbutazone
Suppositories, B.P.

(3) Phenylbutazone
        Tablets, B.P.                       With the written authority of the

Permanent Head-
Acute gout
Rheumatoid arthritis
Sero-negative
spondylo-arthropathies (ankylosing
spondylitis, Reiter's syndrome,
psoriatic arthritis and arthritis
associated with chronic
inflammatory bowel disease)".
7. Omit item 162, substitute the following item:

"162 Sodium Cromoglycate, B.P., Eye
Drops                                       With the written authority of the

Permanent Head-
Vernal kerato-conjunctivitis".
8. Omit item 164, substitute the following item:

"164 Sodium Cromoglycate, B.P.,
Nebuliser Solution                          With the written authority of the

Permanent Head-
For use in a power-operated
nebuliser for the treatment of
asthma in children who have not
attained the age of eight (8)
years".